Yuvimont-FX Chewable Tablet is a combination medication containing Montelukast 10 mg and Fexofenadine 120 mg, formulated to provide effective relief from allergic conditions. Montelukast, a leukotriene receptor antagonist, works by blocking substances in the body called leukotrienes that cause allergy symptoms such as inflammation, swelling, and constriction of airways. Fexofenadine, a second-generation antihistamine, selectively inhibits peripheral H1 receptors, reducing symptoms like sneezing, itching, watery eyes, and nasal congestion without causing significant sedation. This synergistic combination is indicated for the management of allergic rhinitis, chronic urticaria, and other hypersensitivity reactions where both leukotriene-mediated inflammation and histamine release contribute to symptomatology. Yuvimont-FX Chewable Tablet offers the convenience of a chewable form, enhancing patient compliance, especially in pediatric and geriatric populations. It is recommended to be taken once daily, preferably in the evening, with or without food. Caution is advised in patients with hepatic impairment or hypersensitivity to any component. Common side effects may include headache, gastrointestinal discomfort, and mild sedation. Consultation with a healthcare professional is essential before initiating therapy to ensure appropriate use and to monitor for potential adverse effects or drug interactions.